YZT-47165-35784
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 905 / CA
- Registered
- 2022-07-02
- Relationship
- Child or adolescent in my care
- Guardian
- 3ES-74817-75177
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-01
Dose 1 — Moderna
-
2022-07-02
Registered in v-safe
- 2022-07-02
- 2022-07-03
- 2022-07-04
-
2022-07-05
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-06
- 2022-07-07
- 2022-07-08
-
2022-07-15
Survey response — day 14, dose 1, under 3MedDRA: Nasopharyngitis, Office visit, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Head cold, congestion, mild fever · Healthcare visit (other): PediatricianMedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Report sent to call center — day 14, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-07-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-07-24
-
2022-07-29
Dose 2 — Moderna
- 2022-07-31
- 2022-08-01
-
2022-08-02
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-12
- 2022-08-19
- 2022-08-26
- 2022-09-04
- 2022-09-09
-
2022-10-28
Survey response — 3 months, dose 2, under 3MedDRA: Eye infection, Nasopharyngitis — Feeling: FairFree text: Head cold and eye infectionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Moderna | No |
| 2 | 2022-07-29 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-15 | Successful 2022-07-18 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Head cold and eye infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release